P539: A PHASE 1 STUDY OF HMPL-306, A DUAL INHIBITOR OF MUTANT ISOCITRATE DEHYDROGENASE (IDH) 1 AND 2, IN PTS WITH RELAPSED/REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR 2 MUTATIONS

Detalles Bibliográficos
Autores principales: Hu, Lijuan, Zhao, Wei-LI, Wu, Wen, Wei, Xudong, MI, Ruihua, Hu, Yu, LI, Qiubai, He, Wenjuan, LI, Juan, Dong, Yugang, Wang, Hehua, Zhang, Xuhan, Zhang, Yu, Xu, Zhongyuan, Liu, Hui, Cai, Zhen, Sun, Jie, Xu, Yajing, Jiang, Zhiping, Zhang, Cheng, Chen, Guo, Gong, Tiejun, Tang, Qinghua, Jing, Hongmei, MA, Lan, Gao, Sujun, Liu, Qiqi, Zhong, Zeyu, Ren, Yongxin, Chen, Jian, Fan, Songhua, Shi, Michael, Su, Weiguo, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429314/
http://dx.doi.org/10.1097/01.HS9.0000969064.86312.d3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429314/
http://dx.doi.org/10.1097/01.HS9.0000969064.86312.d3

Ejemplares similares